Open AccessReply to Decroo et al.: High-Dose First-Line Treatment Regimen for Recurrent Rifampicin-Susceptible Tuberculosis
Author(s) -
Kelly E. Dooley,
Sachiko Miyahara,
Florian von Groote-Bidlingmaier,
Xin Sun,
Richard Hafner,
Susan L. Rosenkranz,
Elisa H. Ignatius,
Eric L. Nuermberger,
Laura Moran,
Kathleen Donahue,
Susan Swindells,
Naadira Vanker,
Andreas H. Diacon
Publication year - 2020
Publication title -
american journal of respiratory and critical care medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.272
H-Index - 374
eISSN - 1535-4970
pISSN - 1073-449X
DOI - 10.1164/rccm.202002-0359le
Subject(s) - medicine , rifampicin , tuberculosis , regimen , second line , first line , tb treatment , pathology